SATURDAY, NOVEMBER 2, 2019

Middle East Fertility Society

SATURDAY, NOVEMBER 2, 2019

Saturday 2 November, 2019

09:00 - 10:00

ORAL PRESENTATIONS SESSION 3: Assisted Reproductive Technologies
Chair:  Yehia Al Faisal (Egypt), Hazem Al Rumaih (Kuwait)
09:00  O65 Impact of Mitochondrial DNA copy number on assisted reproductive technology outcome in patients undergoing pre-implantation genetic testing for aneuploidy
Chadi Fakih (Lebanon)
09:15  O66 Replacing antagonist by clomiphene citrate to prevent premature ovulation: is it possible?
Imad Aboujaoude, (Lebanon)
09:30  O67 Impact of Endometrial Thickness on the success rate of Intracytoplasmic Sperm Injection (ICSI) at Royal Care International Hospital Fertility Center
Mariam Melik (Sudan)
09:45  O68 Hormone replacement therapy and successful pregnancy in a patient with premature ovarian failure
Galia Milad (Libya)
Room: Saraya 1

09:00 - 10:00

ORAL PRESENTATIONS SESSION 4: Assisted Reproductive Technologies
Chair: Mirali Chahnez (Algeria), Ali Husseini (Iraq)
09:00  O69 Serum estradiol and progesterone levels impact on clinical and chemical pregnancy rates in frozen
embryo transfer cycles
ozkan aydin leylek (Turkey)
09:15  O70 Low LH level on the day of GnRH agonist trigger is associated with reduced ongoing pregnancy and
live birth rates and increased early miscarriage rates following IVF/ICSI treatment and fresh embryo transfer
Abdelhamid Benmachiche, (Algeria)
09:30  O71 Impact of high progesterone level the day of trigger on blastocyst quality in GnRh antagonist
IVF/ICSI cycles: is there an evidence?
Samira Barbara (Algeria)
09:45  O72 Comparison between natural cycle and artificial cycle in frozen–thawed embryo transfers:
retrospective cohort study
Qamhia (Palestine)
Room: Saraya 2

10:00 - 10:30

Coffee Break

10:30 - 12:30

ORAL PRESENTATIONS SESSION 5: Assisted Reproductive Technologies
Chair:  Mansour AlOrf (Kuwait), Walaa El Deeb (EGY), Ashraf Hany (Egypt)
10:30  O73 Effects of fertility medications on glucose homeostasis and other metabolic parameters in women undergoing in vitro fertilization
Ayla Coussa (UAE)
10:45  O74 The Consequence of Exercise Therapy among Menopausal Women
Asma Bin Zablah (Libya)
11:00  O75 Prediction of Premature Ovarian Insufficiency and Prevalence of Medical Diseases
Mlitan H (Libya)
11:15  O76 Exercise as an Intervention in Reducing Side Effects of Breast Cancer
Qais Gasibat (Libya)
11:30  O77 Individualized controlled ovarian stimulation for ART
Ayman Nady Abdelmeged (Egypt)
11:45  O78 Treatment of Infertile PCOS patients with optimal results and decrease the rate of OHSS
Rasekhjahromi Athar,(Iran)
12:00  O79 Optimal results of Palm pollen in the treatment of infertile men
Rasekh Jahromi Athar (Iran)
Room: Saraya 1

10:30 - 12:30

ORAL PRESENTATIONS SESSION 6: Assisted Reproductive Technologies
Chair: Ahmad Elhelaly (Egypt), Abdel Gawad Metwally (Egypt)
10:30  O80 A double-blind, randomized trial of a cytokine-enriched medium in human embryo culture after ICSI
Mohamed Fawzy (Egypt)
10:45  O81 Morphometry of human embryos that resulted in pregnancy
Yousef Alhelou (UAE)
11:00  O82 Case study: A healthy baby delivery using double thawed-frozen oocytes and sperm
Lina Herimat (Palestine)
11:15  O83 The effect of Reproductive methods on pregnancy outcome following hysteroscopic adhesiolysis in patients with Asherman’s syndrome
Saeed Baradwan (KSA)
11:30  O84 The diagnostic accuracy of 3-dimensional saline infusion transvaginal ultrasound (3-D SIS) compared with combined laparoscopic -hysteroscopic procedure in distinction between septate and bicornuate uteri
Mahbod Ebrahimi (Iran)
11:45  O85 The relation of pregnancy, Sexual function and quality of life in Iranian Women
Safieh jamali, (Iran)
Room: Saraya 2

 

12:30

Meeting at Exhibit